RESULTS
Relations between vreanancu weeks and serum levels of CAP, HPL and SP-1
The values of CAP, HPL and SP-1 obtained in the blood of the normal women in the third trimester of pregnancy are presented in Tables 1-3 . All these marker 
Use of prediction curves for values of marker substances
For practical use of this chart, the values of the marker substance will be measured initially in the 30th through the 32nd week of gestation, then the measured values in a row will be plotted on the extended curve in the chart. That will be enough to identify predicted values at later weeks (full and decimal notation) 
DISCUSSION
Various phenomena in pregnancy, variable with time, should be interpreted dynamically. Placental function, the most typical of those, can never be judged adequately by a single determination of any of placenta-specific substances in the maternal blood, because it is difficult to ascertain whether the value at a certain point indicates one on the elevating course or another in the declining process, not allowing of linking it to the state of the placenta. In addition, as described in our preceding report on HSAP, the values of placenta-originating substances individu ally vary so outstandingly in the maternal peripheral blood that their levels, high or low, could not be related to favorable or unfavorable placental function. Ensur ing that the normal range of the values of a marker substances is in no way identifi able in general pregnancy, but it can be indicated on an individual basis in each pregnant woman, we have been insisting that the pattern of shift in the individual level of a marker substance in the maternal blood would be emphasized as significantly helpful to the diagnosis of individual placental function (Yamaguchi et al. 1968) . In succession to the preceding study substantiating our view in the example of HSAP, we pursued in the present study the patterns of shift in the maternal blood levels of other placenta-specific substances, CAP, LAP and SP-1, to ascertain whether they could behave like HSAP.
As the result, it has been realized that our argument is alike favorable in these substances.
Another feature worthy of note in the findings of the present experiment includes: the tested three marker substances along with HSAP shift in nearly identical patterns in their concentrations in the maternal blood as far as the pregnancy progresses normally, but their critical points (turn from rising to falling in level) are different from one another, and in abnormal pregnancy, these substances not always show changes in level in the same manner.
Such phenomena can be considered rather natural in view of the possible difference in their location in the placenta and their dissimilar role in metabolism.
But, from another point of view, the difference in behavior of these substances itself should rather be underscored as suggesting abnormal circumstances involving the placenta.
The significance of the role of such marker substances in pregnancy mostly remains uncertain except for HPL.
However, their dissociations of patterns of shift in maternal blood level in abnormal pregnancy were already pointed out by Aoba et al. (1973) and ourselves (Shimozato and Yamaguchi 1974) . It is emphasized that in reference to the predicted curves, analytical investigations performed into the shifting patterns of marker substances and their dissociations along with their quantitation to help evaluate pathological changes of the placenta.
